chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Moderna vaccine booster given at 2:02 PM with subsequent symptoms of eyes burning, strained, and ?not feeling right.?  Medical provider called to assess at 1417. ROS otherwise negative. Vital signs done at 1417 which included a blood pressure 134/82, oxygen saturation 95% on room air, pulse 71.  He seemed concerned and attributed all of this to the vaccine noting that after the first 2 vaccines he has had to have extensive GI work-up including a HIDA scan and a camera pill and multiple ER visits.  His doctor initially told him not to get the vaccine but then cleared him for this booster dose. His current symptoms include that he feels that his "eyes are not right? and ?feels off.?  No rash, itching, trouble breathing, chest pain, headache 1435 another set of vitals were done with an oxygen saturation of 97%, pulse 72, blood pressure 146/95.  His sclerae white, pupils equal and extraocular movements are intact.  There is no facial asymmetry.  He denies blurry vision.  Oropharynx is clear.  He is moving his arms and legs symmetrically.  His speech is clear.  Mentation is clear.  Heart is regular in rate and rhythm, lungs are clear to auscultation with unlabored respirations.  He reports that his oxygen normally runs normal. At 1448 his oxygen saturation was 95% and he feels drawn out, "does not feel right" and is developed a pain in his R jaw which a few minutes later he noted moved down into his throat.  He has no drooling or trouble swallowing and denies flatly any shortness of breath or wheezing.  Lungs clear with good aeration. Oxygen 2 L nasal cannula was applied. At 1453 he reports discomfort in his upper chest extending from his jaw, skin is warm and dry, heart is regular in rate and rhythm respirations are unlabored.  No scratching of his throat difficulty swallowing or drooling.  Exam unremarkable.  Shortly thereafter began to complain of nausea ?I never throw up.? 1454 oxygen saturation 98% on 2 L pulse 71. EMS arrived shortly thereafter ? report given, and they assumed care. To transport to hospital.  Patient was able to stand up and walk to the stretcher.  His skin was warm and dry.
Patient was given the second dose of Hepatitis A vaccine on 9/7/22, however it was too early since the first dose was given on 3/13/22 and it must be 6 months apart. The pt will have to return to the office for a second dose after 3/7/2023. The provider was made aware.
pt recv vax 11JUN96 & 18JUN96 pt devel several lesions & was treated w/med;pt became pregnant;
At approximately 1 hr and 40 minutes after my injection, I had a chill, which almost immediately turned into total body shaking, rigors.  The shaking was so severe that I was having  trouble breathing between the shakes.  I also had 1 emesis.  At approximately 20 minutes of shaking, I called 911 at the advice of a nurseline.  EMTs checked my vitals and my BP, pulse, O2 sat and blood sugar was all normal.  I almost had another emesis.  They offered to take me to an ER, but I declined as I couldn't see what could be done for me at that point.  At about 40 minutes of symptoms they began to abate.  I then slept for 11 hours straight.
Client given an expired dose of Twinrix on 1-11-08; Client contacted and advised of situation. No adverse effects reported. Twinrix #1 will be repeated 2-12-08
Fever up to 101.3 for 55 hours Chills for 55 hours Body Aches for 55 hours Headache for 72 hours Fatigue for 72 hours Nausea for one hour Sore arm for 72 hours
Site: Pain at Injection Site-Mild, Systemic: Allergic: Difficulty Breathing-Mild, Systemic: Headache-Mild, Systemic: Shakiness-Severe, Additional Details: Patient given Moderna booster injection; did not tolerate well. C/O headache, dry throat, shakiness. Upon assessment vital signs 98.1 temp, 154/86 BP, 24 RR, 99% O2 SATS. Fingerstick # 124. No s/s of sweating, alert & oriented x3. Denied pain. Call placed to # 911. Transported to hospital via ambulance. Husband at her side, stated my wife is not immunocomprise but she and I both has diabetes.
Information has been received from a physician concerning a 25 year old female patient with no pertinent medical history and no drug reactions or allergies who on 29-MAR-2011 was vaccinated with the first dose of GARDASIL (route, dose and lot number not provided) at the patient's gynecologist office (name of gynecologist not reported). Concomitant therapy included oral contraceptives (unspecified). On 29-MAR-2011 at an unspecified time in the evening, the patient experienced abdominal pain, cramping and a low grade headache. The physician reported that the patient's abdominal pain and cramping subsided on 31-MAR-2011. The patient's low grade headache became worse and the patient came to the physician's office on 01-APR-2011 with an ocular migraine. The ocular migraine was alleviated with the use of MOTRIN (dose and manufacturer unspecified). The physician reported that the patient complained of "a little" dizziness on 01-APR-2011 "today". No laboratory diagnostics studies were performed. At the time of the report, the patient was recovering. Additional information has been requested.
I became quite ill starting overnight after receiving my second Moderna shot with a very sore arm, chills, extreme fatigue, thirst, and extreme body aches. By the morning of the 12th of May, I developed tachycardia (my heart rate was going up as high as 132 for the entire day), fever close to 102°, nausea, dizziness, and extreme sweat. Most of these things stopped by the following morning, thankfully. But after that starting the 13th of May, I have developed nerve pain in my left hand (at first it was constant but now it is intermittent; it began in the thumb and then traveled to other fingers as well but now is primarily in the thumb whenever it comes back), continued arm soreness, and constant tinnitus (which sometimes is louder than other times), all of which is continuing to this point.
fever 108C; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever 108C) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Feb-2021, the patient experienced PYREXIA (fever 108C). At the time of the report, PYREXIA (fever 108C) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 14-Feb-2021, Body temperature: 108c (High) 108C.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided. Treatment information was not reported.
Missed miscarriage.  Details about the pregnancy - EDD Nov02, 2021. First pregnancy. Tracking ovulation and dates.  Mar19 - first dose of Pfizer. Mar22 - first ultrasound, detected sac/fetal pole, heart rate detected by slow at 100bpm. Measuring 1 week behind, pushing EDD to Nov12 Mar29 - second ultrasound, no heartbeat detected, no growth from previous week.  Still had pregnancy symptoms, did not have symptoms after vaccine dose 1.
Intense burning during shot. ( I told him too.  2 days later, pain began in shoulder area and radiated down left arm. Continual pain for 20 days throughout arm. Some weakness significant loss of use of left arm to do the simplest things. Never had any shoulder issues EVER! Doctor put me on steroids and Tramadol. STILL EXPERIENCING DIFFICULTY using left arm and significant , consistent pain not relieved by Ibuprophen or Tylenol.  Cannot sleep in any position. Going to see an orthopedic doctor Friday, Nov15, 2019
Rash on arm painful red hot and itchy. I?m not worried but thought it should be known
Unknown if an adverse reaction occurred. This was a duplicate vaccination for COVID 19. Patient had already received a dose of Comirnaty COIVD vaccine on 10/12/2023.
within 12 hours, very high fever (105.9), flushing, chills.   Fever >103 lasted 3 days.
This spontaneous case reported by a consumer, describes the occurrence of pyrexia (low-grade fever), vaccination site pain (the site of the vaccine was painful/soreness in arm), blurred vision (blurry circle vision on one eye), fatigue (tired) and asthenia (I've been weak) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch# 025J202A) for COVID-19 immunization. The occurrence of additional events detailed below. No medical history reported. On Feb 11, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On Feb 11, 2021, patient experienced fatigue (tired) and asthenia (I've been weak). On Feb 13, 2021, patient experienced pyrexia (low-grade fever). On Feb 15, 2021, patient experienced blurred vision (blurry circle vision on one eye). On an unknown date, patient experienced vaccination site pain (the site of the vaccine was painful/soreness in arm) and pain (painful to lay on). On Feb 14, 2021, fatigue (tired) resolved. On Feb 15, 2021, pyrexia (low-grade fever) and blurred vision (blurry circle vision on one eye) resolved. At the time of the report, vaccination site pain (the site of the vaccine was painful/soreness in arm), asthenia (I've been weak) and pain (painful to lay on) resolved. The action taken with mRNA-1273 (Moderna COVID-19 vaccine), intramuscular: unknown.
This spontaneous report was received from a nurse practitioner via company representative refers to a 25 year old male patient. Medical history and concurrent conditions were not reported. On 06-FEB-2015 the patient was vaccinated with the first dose of GARDASIL injection, 0.5 ml, intramuscular (lot # and expiration date were not reported). Concomitant therapy was not reported. The nurse practitioner informed that on 07-FEB-2015 (also reported as "a day after") the patient developed left side throat and ear pain, the patient went to the urgent care and was prescribed prednisone, the patient returned back to the health care professional office on 09-FEB-2015 and complained of the same symptoms and he was given ciprofloxacin and unspecified pain medication. The outcome of the left sided throat and ear pain was unknown. Additional information has been requested.
Patient with inoperable pancreatic cancer received second Pfizer vaccine approximately 12:30 pm on 1/27/21. At approximataely 16:30, patient complained of abdominal pain and was given Levsin 0.125mg and morphine 5mg orally.  At approximately 19:30 patient was found on the floor covered in a large amount of emesis, unresponsive  without a pulse.
I got fully vaccinated 4/2 and 4/23 and booster 11/13. On 12/19 I developed acute appendicitis and was hospitalized for laparoscopic surgery which treated the issue. I do not blame the vaccine for the appendicitis and I stand by and do not regret my choice to get vaccinated. I report this for the sake of science.
Headaches - temporal started the evening that vaccines given. Headaches woke her at night - no nausea or vomiting. No neuro deficits. Headache comes and goes.
Initial and follow-up information has been received from a pharmacist concerning a 65 year old female who on 10-OCT-2008 was vaccinated with the second dose of PNEUMOVAX (Lot# 660685/0619X) 0.5ml IM left deltoid. She had no drug reactions/allergies. The patient had no illness at the time of vaccination. On 11-OCT-2008 the patient developed an injection site reaction. The injection site was red, raised, hard and warm. The patient could not lift the injection site arm. The injection site reaction was 3 and 1/2 inches in length described as oblong. The patient was nauseous. She could not eat which lasted about 2 days. The patient was slight dizzy. Subsequently, the patient recovered. No further information was available.
Twitching in back of legs, throat swelling, heart palpitations, difficulty swallowing, difficulty breathing, swelling of tongue 12/02/09 Medical record received for DOS 11/11/09. Presented with headache, sinus pressure x 3 weeks; requesting second gardasil  injection. DX: Acute bacterial sinusitis
Left arm slightly swollen and warm (as with first 3 shots), but muscle/joint aches/pains starting 2-3 days later, beginning with left shoulder and right hip/groin.  Progressed to other joints over next two weeks with fatigue and extreme weakness for all muscles.  Received interim approval for naproxen at 2 weeks to control inflammation and physical therapy at 4 weeks to help with mobility and muscle atrophy. Condition still not improving after 2 months of medical options.  Blood lab results showed high CRP (4) and ESR (119) and doctor diagnosed polymyalgia rheumatica.  Started prednisone 15 mg and conditioned improved in less than 12 hours. Now working with rheumatology for therapy.
welp covered large portion of patient's outer arm/red welt/welt pain/Swelling; hot to the touch; This case was reported by a pharmacist via call center representative and described the occurrence of injection site wheal in a 56-year-old female patient who received Herpes zoster (Shingrix) (batch number K9M5N, expiry date 7th November 2021) for prophylaxis.   On 20th August 2019, the patient received the 1st dose of Shingrix (intramuscular) .5 ml. On 25th August 2019, 5 days after receiving Shingrix, the patient experienced injection site wheal and injection site warmth. On an unknown date, the outcome of the injection site wheal was not recovered/not resolved and the outcome of the injection site warmth was unknown.   It was unknown if the reporter considered the injection site wheal and injection site warmth to be related to Shingrix.  Additional details were provided as follows: The patient received a dose of Shingrix in the right deltoid. The patient presented with a welt that covered a large area of the patient's right arm.  Welt described as being between the size of a saucer and dinner plate that took up a large portion on the patient's outer arm.  The welt was approximately 2 inches above the elbow, red, swollen, painful, and hot to the touch. Welt described as uneven and wavy and not smooth.  The pharmacist unsure of welt onset, but certain it did not occur same day as vaccination. The reporter consented to follow up. The pharmacist was the reporter. The pharmacist mentions the patient was not a small person and patient's arm was large, and welt covered large portion of patient's outer arm.
injection site hot; nausea; headache; injection site swollen; injection site hurts; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (injection site hot), NAUSEA (nausea), HEADACHE (headache), VACCINATION SITE SWELLING (injection site swollen) and VACCINATION SITE PAIN (injection site hurts) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, the patient experienced VACCINATION SITE WARMTH (injection site hot), NAUSEA (nausea), HEADACHE (headache), VACCINATION SITE SWELLING (injection site swollen) and VACCINATION SITE PAIN (injection site hurts). At the time of the report, VACCINATION SITE WARMTH (injection site hot), VACCINATION SITE SWELLING (injection site swollen) and VACCINATION SITE PAIN (injection site hurts) had not resolved and NAUSEA (nausea) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
- patient requested "Moderna" on paperwork - dispenser did not calculate age and administered full dose of Moderna in left deltoid - support staff noticed birthdate indicating patient was 16 - patient and mother notified of incident, made aware that Moderna was only for 18+ - patient assessed for adverse effects, no reactions noted - MD notified and recommended 30 minute observation and to follow up with Pfizer as a second dose to complete his series - patient agreeable and placed in observation for 30 minutes - patient and mother counseled on side effects, adverse effects, and to receive Pfizer in at least 4 weeks  - patient and mother verbalized understanding - patient noted no reactions or side effects. counseled to seek medical advice if he experiences any reactions after leaving clinic
headache that comes and goes and was just there; Nausea; Feeling unwell; Had some fatigue as well; In few minutes I started feeling really hot; This is a spontaneous report from a contactable consumer, the patient.  A 33-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: "EL324U"), via an unspecified route of administration on 03Jan2021 (at the age of 33-years-old) as a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported.  In Jan2021, the patient experienced headache that comes and goes and was just there, nausea, feeling unwell, some fatigue, and feeling hot. The patient took ibuprofen and acetaminophen (TYLENOL) for the headache; but did not seem to help. The clinical outcomes of headache, nausea, feeling unwell, fatigue, and feeling hot were unknown.
noticed hair breakage/loss since JUL93, though it is currently subsiding; dermatology consult; traction hair loss secondary to perms; perms hair every 3 months/last perm FEB94;
1st dose on 01Aug2018, 2nd on 03Sep2022; This case was reported by a pharmacist via call center representative and described the occurrence of drug dose administration interval too long in a 54-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose of Shingrix on 1st August 2018).   On 3rd September 2022, the patient received the 2nd dose of Shingrix. On 3rd September 2022, unknown after receiving Shingrix, the patient experienced drug dose administration interval too long. On an unknown date, the outcome of the drug dose administration interval too long was unknown.   Additional Information: GSK Receipt Date: 03-NOV-2022 Reporter's Comment: The reporter reported that, patient was not immunocompromised. The reporter did not consent to follow-up. Additional Supportive Information: The patient received the 2nd dose of Shingrix later than the recommended interval, which led to lengthening of vaccination schedule.
Erythematous raised dry red patches to interior thighs on day 2, continued to spread to posterior thighs over next few days, peak severity and distribution of rash on 1/31/17. No fevers, no other symptoms. The appearance of the rash, the timeline and family history favors eczema but given timing of outbreak, wanted to report. No treatment other than topical hydrocortisone was prescribed. Will monitor for improvement.
Left-sided severe headache and 3 occasion of left-sided facial numbness starting around 3/24/21 10:30 pm. Facial numbness is currently resolved. The severity of headache has improved.
Was not feeling well and ended up not going back to get the 2nd dose; As she was sick a lot/With other illnesses; Missed dose/2nd dose not yet received by the patient/Patient never got the 2nd dose; This spontaneous case was reported by a patient and describes the occurrence of MALAISE (Was not feeling well and ended up not going back to get the 2nd dose), ILLNESS (As she was sick a lot/With other illnesses) and PRODUCT DOSE OMISSION ISSUE (Missed dose/2nd dose not yet received by the patient/Patient never got the 2nd dose) in a 26-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 019F21A) for COVID-19 vaccination.     No allergy was reported.  Patient had not been diagnosed with/ tested positive for COVID-19.     On 08-Oct-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced MALAISE (Was not feeling well and ended up not going back to get the 2nd dose), ILLNESS (As she was sick a lot/With other illnesses) and PRODUCT DOSE OMISSION ISSUE (Missed dose/2nd dose not yet received by the patient/Patient never got the 2nd dose). At the time of the report, MALAISE (Was not feeling well and ended up not going back to get the 2nd dose), ILLNESS (As she was sick a lot/With other illnesses) and PRODUCT DOSE OMISSION ISSUE (Missed dose/2nd dose not yet received by the patient/Patient never got the 2nd dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  No treatment medications were reported.
This is a spontaneous report from a contactable physician communicated through a Pfizer sales representative. This physician reported that he referred a patient to the infectologist. The patient was co-administered Flu and Pneumococcal shots. After vaccinations, the patient reported that had Herpes Zoster. The reporter considered the event related to pneumococcal vaccine. At the time of reporting, it was unknown if the patient had received PREVNAR 13 or PPSV 23. Follow-up (20-MAR-2013): Follow-up attempts completed. No further information expected.
kind of tired/some tiredness; arm hurt/sore arm; little headache; I have not had the 2nd shot of Moderna since December of last year; This spontaneous case was reported by a patient and describes the occurrence of FATIGUE (kind of tired/some tiredness), PAIN IN EXTREMITY (arm hurt/sore arm), HEADACHE (little headache) and PRODUCT ADMINISTRATION INTERRUPTED (I have not had the 2nd shot of Moderna since December of last year) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012H21B) for COVID-19 vaccination.     The patient's past medical history included COVID-19 (She had COVID 2 years ago, prior to receiving any Moderna shots.) and Clot blood (She had to be hospitalized due to COVID and it caused her to have a small blood clot. ). Previously administered products included for Clot blood: Eloquis. Past adverse reactions to the above products included No adverse event with Eloquis.    On 01-Dec-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Dec-2021, the patient experienced FATIGUE (kind of tired/some tiredness), PAIN IN EXTREMITY (arm hurt/sore arm), HEADACHE (little headache) and PRODUCT ADMINISTRATION INTERRUPTED (I have not had the 2nd shot of Moderna since December of last year). On 03-Dec-2021, FATIGUE (kind of tired/some tiredness), PAIN IN EXTREMITY (arm hurt/sore arm) and HEADACHE (little headache) had resolved. At the time of the report, PRODUCT ADMINISTRATION INTERRUPTED (I have not had the 2nd shot of Moderna since December of last year) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was reported. It was reported that she never received her 2nd dose due to work related issues. She mentioned that she had COVID 2 years ago, prior to receiving any Moderna shots. She had to be hospitalized due to COVID and it caused her to had a small blood clot. She stated that she had to take Eloquis for 6 months due to this. No treatment medication was reported.
Pt reported @ 1146 tingling in neck left side (injection side) VS: BP 78/palpated, HR 65, Osat 94%